Microbix Biosystems Inc. (MBXBF)
OTCMKTS · Delayed Price · Currency is USD
0.1580
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Microbix Biosystems Revenue
Microbix Biosystems had revenue of 4.22M CAD in the quarter ending December 31, 2025, a decrease of -30.20%. This brings the company's revenue in the last twelve months to 16.76M, down -27.23% year-over-year. In the fiscal year ending September 30, 2025, Microbix Biosystems had annual revenue of 18.59M, down -26.81%.
Revenue (ttm)
16.76M CAD
Revenue Growth
-27.23%
P/S Ratio
1.92
Revenue / Employee
167.60K CAD
Employees
100
Market Cap
23.45M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 18.59M | -6.81M | -26.81% |
| Sep 30, 2024 | 25.39M | 8.88M | 53.77% |
| Sep 30, 2023 | 16.51M | -2.56M | -13.43% |
| Sep 30, 2022 | 19.08M | 483.28K | 2.60% |
| Sep 30, 2021 | 18.59M | 8.07M | 76.66% |
| Sep 30, 2020 | 10.52M | -2.89M | -21.53% |
| Sep 30, 2019 | 13.41M | 901.78K | 7.21% |
| Sep 30, 2018 | 12.51M | 2.32M | 22.82% |
| Sep 30, 2017 | 10.19M | 668.66K | 7.03% |
| Sep 30, 2016 | 9.52M | 643.23K | 7.25% |
| Sep 30, 2015 | 8.87M | 477.12K | 5.68% |
| Sep 30, 2014 | 8.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HOOKIPA Pharma | 9.35M |
| Zeo ScientifiX | 5.20M |
| Harvard Apparatus Regenerative Technology | 743.00K |
| Zenith Capital | 500.00K |
| Provectus Biopharmaceuticals | 350.44K |
| ZIVO Bioscience | 209.03K |
| Arch Biopartners | 198.11K |
Microbix Biosystems News
- 4 weeks ago - Microbix Updates Investor Presentation on its Website - Accesswire
- 5 weeks ago - Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing - Accesswire
- 7 weeks ago - Microbix Biosystems Inc (MBXBF) Q4 2025 Earnings Call Highlights: Navigating Challenges and ... - GuruFocus
- 7 weeks ago - Q4 2025 Microbix Biosystems Inc Earnings Call Transcript - GuruFocus
- 2 months ago - Microbix Biosystems Inc. (MBX:CA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Microbix Biosystems GAAP EPS of -$0.01, revenue of $3.74M - Seeking Alpha
- 2 months ago - Microbix Schedules Release of Results for Q4 Fiscal 2025 - GlobeNewsWire
- 2 months ago - Microbix Launches New Products to Support H3N2 Flu Testing - GlobeNewsWire